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Trends in treated drug misuse in 
the Republic of Ireland,
The National Drug Treatment Reporting System is an epidemiological database on treated
drug misuse in the Republic of Ireland. It was established in 1990 in the Greater Dublin Area
and was extended in 1995 to cover other areas of the country. The reporting system was
originally developed in line with the Pompidou Group’s Definitive Protocol and subsequently
refined in accordance with the Treatment Demand Indicator Protocol (EMCDDA and
Pompidou Group 2000). The National Drug Treatment Reporting System is co-ordinated by
staff at the Drug Misuse Research Division of the Health Research Board on behalf of the
Department of Health and Children. 
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Compliance with the National Drug Treatment Reporting System requires that one form be
completed for each person who receives treatment for problematic drug use at each
treatment centre in a calendar year. Service providers at drug treatment centres throughout
the Republic of Ireland collect data on each individual treated for drug misuse. At national
level, staff at the Drug Misuse Research Division of the Health Research Board compile
anonymous, aggregated data. 
For the purpose of the National Drug Treatment Reporting System, treatment is broadly
defined as ‘any activity which aims to ameliorate the psychological, medical or social state of
individuals who seek help for their drug problems’. Clients who attend needle-exchange
services and clients who report alcohol as their main problem drug are not included in this
Drug treatment data are viewed as an indirect indicator of drug misuse. These data are used
at national and European levels to provide information on the characteristics of clients
entering treatment, and on patterns of drug misuse, such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess needs,
… and to plan and evaluate services’ (EMCDDA 1998: p23). Information from the National
Drug Treatment Reporting System is made available to service providers and policy makers
and is used to inform local and national drug policy and planning. For example, in 1996
National Drug Treatment Reporting System data were used to identify a number of local
areas with problematic heroin use (Ministerial Task Force 1996). These areas were later
designated as Local Drug Task Force Areas and are continuing to provide strategic responses
to drug misuse in their communities. 
The monitoring role of the National Drug Treatment Reporting System is recognised by the
Government in its document Building on Experience: National Drugs Strategy 2001-2008. Data
collection for the National Drug Treatment Reporting System is one of the actions identified
and agreed by Government for implementation by health boards: ‘All treatment providers
should co-operate in returning information on problem drug use to the Drug Misuse
Research Division of the Health Research Board’ (Department of Tourism, Sport and
Recreation 2001: p118). 
National Drug Treatment 
Reporting System methodology
Treatment demand as an indicator 
of problem drug use
reporting system. Treatment options include one or more of the following: medication (detoxification, methadone
reduction and substitution programmes), addiction counselling, group therapy, psychotherapy and/or life skills
training. Treatment is provided in both residential and non-residential settings. Data returns to the National Drug
Treatment Reporting System for clients attending treatment services during 2000 were provided by 154 treatment
services: 136 non-residential and 18 residential (Table 1). 
The main elements of the reporting system are: 
a) All cases treated – describes individuals who receive treatment for problematic drug use at each treatment 
centre in a calendar year;
b) New cases treated – describes the sub-group of individuals who have never previously been treated for 
problem drug use. 
In the case of the data for ‘all cases treated’ there is a possibility of duplication in the database, for example, where a
person receives treatment at more than one centre. For those receiving methadone maintenance or detoxification, this
possibility is estimated to be small since the introduction of the Misuse of Drugs Regulations in 1998, whereby
precautions are taken to ensure that this treatment is available from one source only. 
In the Republic of Ireland, the number of outpatient treatment centres has increased threefold, from 35 in 1996 to 104
in 2000, while the number of inpatient services has also increased, from 11 to 18 (Table 1). The number of outpatient
and inpatient drug services submitting data to the National Drug Treatment Reporting System is satisfactory. As a result
of the introduction of the revised treatment protocol, the number of general practitioners providing treatment has
increased dramatically, from 125 in 1998 to 187 in 2000, but the number of general practitioners submitting data was
very low (15.5 per cent of a possible 187 who prescribed methadone in 2000). General practitioners who have
completed Methadone Level Two training are permitted to start clients on methadone maintenance. Between
November 1998 and December 2000, general practitioners started 355 patients on methadone maintenance for the
first time (Central Methadone Treatment List, unpublished data). Therefore, the low general practitioner participation
rate indicates that there was an under representation of new cases in the National Drug Treatment Reporting System.
The prison service has never submitted data on a regular basis. Up to 2001, the only drug treatment service available
in Irish prisons was a detoxification programme in the Medical Unit of Mountjoy Male Prison. Between 1996 and 1999,
87 individuals completed the programme (Crowley 2000). The average age of the prisoners was 26 years and the
average sentence length was four years. Even if these were all new cases, it is unlikely that the 30 patients treated each
year would affect the overall treatment incidence rate in a given year. 
Out of a total number of 6994 cases treated in 2000, 80 per cent were treated at outpatient services; 11 per cent were
treated at inpatient services, five per cent at low threshold services and four per cent at general practice (Table 1). 
Table 1   Number and type of services providing treatment for drug addiction and number of clients treated
(in brackets) as recorded in the National Drug Treatment Reporting System in the Republic of Ireland, 1996
to 2000
Drug services 1996 1997 1998 1999 2000
Outpatient 35 (3084) 44 (3564) 81 (4551) 85 (4659) 104 (5584)
Inpatient 11 (1208) 16 (1164) 16 (1272) 16 (1004) 18 (796)
Low threshold 1 (21) 2 (180) 4 (192) 5 (347) 3 (340)
General practitioner 1 (4) 1 (2) 1 (24) 44 (426) 29 (274)
Prison 1 (154) 0 (0) 2 (4) 2 (7) 0 (0)
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Treatment provision
Given the complex nature of problems associated with drug misuse, it is recognised that there is no single treatment
modality for problem drug use. Consequently, a broad range of services covering treatment and rehabilitation is
provided throughout the country (O’Brien et al 2002). There is variation in the type of service provided in different
regions. Drug substitution programmes (opiate detoxification, methadone reduction, methadone maintenance),
syringe-exchange programmes and rehabilitation programmes are provided mainly in the health board areas in the
eastern region where most of those seeking treatment report that heroin is their main problem drug. Substitution
programmes are increasingly becoming a feature of drug services in many regions. Addiction counselling services are
provided in all regions of the country. Of all treated cases who had details returned to the National Drug Treatment
Reporting System for 2000 (6994), half were receiving long-term methadone maintenance, almost one-fifth started
detoxification, two-fifths had some counselling and one-tenth commenced psychosocial therapy.   
The number of cases presenting for treatment and reported to the National Drug Treatment Reporting System
increased consistently, from 4865 in 1996 to 6994 in 2000 (Table 2). This was attributed to an increase in drug use, an
increase in service provision, and an increase in the number of centres providing information. 
In contrast, the number of people who presented for treatment for the first time ever (new cases) fell from 2034 in
1996 to 1622 in 1998 (Table 2). The decreasing trend in service uptake by new clients did not continue in 1999 and
2000, when the numbers increased somewhat to 1846 and 1978 respectively. The reason for the decrease in numbers
of new cases in 1997 and 1998 is not altogether clear but may reflect a tapering off of the heroin epidemic in the
Dublin area. The increase in new cases in 1999 and 2000 reflects the expansion in drug treatment services and the
increase in reporting to the National Drug Treatment Reporting System outside the Greater Dublin Area. 
Extent of the problem
Socio-demographic information
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Between 1996 and 2000, the typical client coming for treatment was male, in his early twenties and lived in the family
home (Table 3a). In 2000, fewer clients were now living in the family home; the proportion fell from 69 per cent in
1996 to 61 per cent in 2000 (Table 3a). Closer examination of the data shows that the proportion of clients who said
that they were homeless increased by two per cent; the number more than doubled from 114 in 1996 to 305 in 2000
(not shown in table). In educational terms, the proportion of those who had left school before the age of 15 remained
relatively high at just over one-quarter (Table 3a). One aspect of the social condition of clients showed definite signs of
improvement: the employment level increased from 11 per cent in 1996 to 28 per cent in 2000 (Table 3a). This was
not surprising given the favourable economic conditions in the country during that time, although the percentage was
still very low in comparison to that of the general population. The data presented in tables 3a and 3b are indicative of
the social disadvantage of drug users and present a challenge to policy makers, particularly in the areas of education
and employment, if social exclusion and marginalisation issues are to be addressed. 
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
‡ Left school before the age of 15 years.
Table 2   Number of cases (all and new) reported to the National Drug Treatment 
Reporting System in the Republic of Ireland, 1996 to 2000
Year All cases* New cases
Number
1996 4865 2034
1997 4910 1521
1998 6043 1622
1999 6443 1846
2000 6994 1978
Table 3a   Socio-demographic characteristics of all cases attending treatment in the Republic of Ireland and
reported to the National Drug Treatment Reporting System, 1996 to 2000 
Characteristics* 1996 1997 1998 1999 2000
Mean age in years 23.6 24.2 24.7 25.4 25.7
Median age (range)† in years 22 (16-36) 23 (16-37) 23 (17-38) 24 (17-38) 24 (17-39)
Number (%) under 18 years of age 723 (14.9) 610 (12.4) 538 (8.9) 379 (5.9) 459 (6.6)
Number (%) of males 3455 (72.0) 3322 (69.3) 4165 (70.2) 4432 (69.0) 4927 (70.7)
Number (%) living with parents/family 3227 (69.4) 3052 (65.4) 3817 (65.7) 3853 (62.7) 4099 (60.9)
Number (%) of early school leavers‡ 1199 (29.1) 1133 (28.3) 1332 (27.7) 1408 (27.1) 1687 (28.5)
Number (%) still in education 220 (5.0) 222 (5.0) 192 (3.7) 195 (3.4) 242 (3.8)
Number (%) employed 504 (10.5) 691 (14.5) 1139 (19.7) 1614 (26.1) 1884 (28.0)
Total* 4865 4910 6043 6443 6994
As expected, between 1996 and 2000 new clients were somewhat younger than the overall treated group, with a
higher proportion of young people less than 18 years of age (Tables 3a and 3b). In the period under review, there was
a decline in the proportion of young people presenting to drug treatment services; the proportion of young new
* Number of cases, as distinct from individuals, who received treatment for problem drug use; this includes new cases, previously treated cases and cases whose treatment
status is unknown. Cases whose treatment status is unknown comprise 2.5% of all cases and may include some new cases.  
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clients (under 18 years) fell from 25 per cent in 1996 to 16 per cent in 2000 (Table 3b). This could be a reflection
of the limited access to drug services meeting the specific needs of young people, particularly in Dublin, rather than
a real reduction in drug use. The National Children’s Strategy has identified the need for specialist adolescent
addiction services in view of the different needs of young people (National Children’s Strategy 2000). 
During the reporting period, the proportion of new clients who lived in the family home fell from 77 per cent in
1996 to 68 per cent in 2000 (Table 3b). Employment levels among new clients were higher than those of the
overall group, and they show an increasing trend, from 14 per cent in 1996 to 32 per cent in 2000 (Table 3b).
Information on the patterns of drug use, such as the types of drugs being used, how they were taken, and whether they
were taken in combination with other drugs, is useful in assessing and planning drug treatment services. Opiates were
the main drugs for which people presented for treatment. Most people presenting for treatment for opiate misuse did so
in the three health board areas in the eastern region. Consequently, Irish drug misuse trends were dominated by data
from these health board areas. Of those seeking treatment for problem drug use over the period 1996 to 2000,
approximately four-fifths of those treated reported that their main problem drug was an opiate (Table 4a). The number
of all (opiate) contacts increased from 3840 in 1996 to 5333 in 2000 (Table 4a), but the proportion reporting opiates as
their main drug declined to its lowest level in the five-year period under review.  In comparison, the proportion
presenting with other types of drug problems was relatively small (Table 4a). Problematic cannabis use increased, from a
stable 11 per cent in 1997, 1998 and 1999, to 16 per cent in 2000 (Table 4a). According to the drug co-ordinators
outside the Eastern Regional Health Authority area, alcohol is the main problem drug for which people seek treatment in
these regions and this is not taken account of in the National Drug Treatment Reporting System. In the Eastern Regional
Health Authority, treatment seeking for problem alcohol use may also be very common, but has not been highlighted by
the management within the addiction services in this area. 
Table 4a   Main problem drug reported by all cases attending treatment in the Republic of Ireland and
recorded in the National Drug Treatment Reporting System, 1996 to 2000
Main drug misused 1996 1997 1998 1999 2000
Number (%)
Opiates 3840 (79.0) 3904 (79.8) 4872 (80.8) 5269 (81.7) 5333 (76.3)
Cocaine 25 (0.5) 42 (0.9) 86 (1.4) 58 (0.9) 78 (1.1)
Ecstasy 256 (5.3) 246 (5.0) 195 (3.2) 215 (3.3) 290 (4.1)
Amphetamines 19 (0.4) 51 (1.0) 72 (1.2) 62 (1.0) 30 (0.4)
Benzodiazepines 57 (1.2) 60 (1.2) 95 (1.6) 50 (0.8) 99 (1.4)
Volatile Inhalants 25 (0.5) 27 (0.6) 35 (0.6) 32 (0.5) 42 (0.6)
Cannabis 584 (12.0) 519 (10.6) 634 (10.5) 728 (11.3) 1081 (15.5)
Other substances 52 (1.1) 45 (0.9) 41 (0.7) 29 (0.5) 41 (0.6)
Valid number 4858 4894 6030 6443 6994
Opiate use was less common among the sub-group of new cases, and the trend decreased from 66 per cent in 1996 to
47 per cent in 2000 (Table 4b). As might be expected, cannabis use was higher among new clients and the proportion
reporting cannabis as a problem drug increased from 21 per cent in 1996 to 36 per cent in 2000 (Table 4b), reflecting
an increase in cannabis use, in service provision, and in the number of centres providing information. 
Table 3b   Socio-demographic characteristics of new cases starting treatment in the Republic of Ireland and
reported to the National Drug Treatment Reporting System, 1996 to 2000
Characteristics* 1996 1997 1998 1999 2000
Mean age in years 21.2 22.0 22.1 23.2 23.2
Median age (range)† in years 20 (15-32) 21 (15-34) 21 (16-33) 22 (16-36) 22 (16-36)
Number (%) under 18 years of age 501 (24.6) 320 (21.0) 308 (19.0) 243 (13.2)         322 (16.3)
Number (%) of males 1462 (72.8) 1067 (71.3) 1194 (74.5) 1337 (72.7) 1517 (77.0)
Number (%) living with parents/family 1509 (76.6) 1048 (71.3) 1141 (71.1) 1229 (68.9) 1312 (67.8)
Number (%) of early school leavers‡ 409 (24.7) 253 (21.5) 282 (23.2) 327 (22.8) 311 (20.7)
Number (%) still in education 164 (8.8) 142 (10.1) 129 (9.0) 138 (8.2) 188 (10.4)
Number (%) employed 276 (13.8) 287 (19.2) 388 (24.8) 552 (30.9) 611 (31.8)
Total* 2034 1521 1622 1846 1978
* It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had complete data. 
† Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
‡ Left school before the age of 15 years.
Problem drug use
Respondents who reported that opiates were their main problem drug were examined separately and this revealed that
the proportion using heroin rather than other opiates had increased by five per cent, from 88 to 93 per cent between
1996 and 2000 (Table 5a). The numbers involved in heroin use increased from 3384 in 1996 to 4942 in 2000. Among
opiate users there was an upward trend in injecting heroin use, from 53 per cent in 1996 to 70 per cent in 2000 and
this has very serious implications for the health of opiate users (Table 5a). The use of other opiates such as codeine,
dihydrocodeine and methadone was stable between 1996 and 1998, and decreased in 1999 and 2000 (Table 5a),
perhaps indicating that heroin, the drug of choice, was more readily available or that there were tighter regulations on
prescription opiates. During the reporting period, opiate/heroin use was concentrated mainly in the Dublin area. 
The number of heroin users presenting for treatment for the first time fell from 1288 in 1996 to 888 in 2000 (Table 5b).
The pattern of heroin use among new clients in Dublin during the early 1990s was characterised by the emergence of
chasing the dragon (Smyth et al 2000). This coincided with a surge in the number of young people entering treatment
for the first time. In 1996, new clients were more likely to smoke rather than inject the heroin (Table 5b). Between 1997
and 1999, there was an increase in the proportion who reported injecting heroin and a corresponding decrease in the
proportion smoking heroin. It would seem that heroin users, who initially were reluctant to inject the drug, were more
willing to do so once the heroin use had become habitual (Cassin et al 1998; Dillon 2001; Moran et al 2001). The
upward trend in intravenous heroin use among new clients did not continue into 2000, when the route of
administration was almost equally divided between injecting and smoking (Table 5b). 
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Table 4b   Main problem drug reported by new cases starting treatment in the Republic of Ireland and
recorded in the National Drug Treatment Reporting System, 1996 to 2000
Main drug misused 1996 1997 1998 1999 2000
Number (%)
Opiates 1337 (65.8) 933 (61.5) 969 (59.9) 1122 (60.8) 934 (47.2)
Cocaine 17 (0.8) 22 (1.5) 32 (2.0) 28 (1.5) 33 (1.7)
Ecstasy 191 (9.4) 159 (10.5) 120 (7.4) 143 (7.6) 208 (10.5)
Amphetamines 13 (0.6) 34 (2.2) 37 (1.9) 36 (2.0) 19 (1.0)
Benzodiazepines 13 (0.6) 19 (1.3) 23 (1.4) 12 (0.7) 25 (1.3)
Volatile inhalants 18 (0.9) 12 (0.8) 22 (1.4) 20 (1.1) 31 (1.6)
Cannabis 420 (20.7) 318 (21.0) 397 (24.5) 474 (25.7) 703 (35.5)
Other substances 23 (1.1) 19 (1.3) 19 (1.2) 11 (0.6) 25 (1.3)
Valid number 2032 1516 1619 1846 1978
Table 5a   All cases attending treatment in the Republic of Ireland and reporting an opiate as the main
problem drug, as recorded in the National Drug Treatment Reporting System, 1996 to 2000
Opiate primary drug and 1996 1997 1998 1999 2000
its route of administration
Number (%)
Heroin users of whom: 3384 (88.1) 3442 (88.2) 4323 (88.7) 4878 (92.6) 4942 (92.7)
injected 1776 (52.5) 2227 (64.7) 2829 (65.4) 3436 (70.4) 3458 (70.0)
smoked 1526 (45.1) 1146 (33.3) 1337 (30.9) 1354 (27.8) 1405 (28.4)
other route 3 (0.1) 23 (0.7) 26 (0.6) 24 (0.5) 15 (0.3)
not known 79 (2.1) 46 (1.3) 131 (3.0) 64 (1.3) 64 (1.3)
Other opiate users 456 (11.9) 462 (11.8) 549 (11.3) 391 (7.4) 391 (7.3)
Valid number 3840 3904 4872 5269 5333
Table 5b   All new cases starting treatment in the Republic of Ireland and reporting an opiate as the main
problem drug, as recorded in the National Drug Treatment Reporting System, 1996 to 2000
Opiate primary drug and 1996 1997 1998 1999 2000
its route of administration
Number (%)
Heroin users of whom: 1288 (96.3) 894 (95.8) 907 (93.6) 1074 (95.7) 888 (95.1)
injected 471 (36.6) 432 (48.3) 448 (49.4) 627 (58.4) 442 (49.8)
smoked 784 (60.9) 448 (50.1) 445 (49.1) 433 (40.3) 434 (48.9)
other route 1 (0.1) 4 (0.4) 4 (0.4) 4 (0.4) 5 (0.5)
not known 32 (2.5) 10 (1.1) 10 (1.1) 10 (0.9) 7 (0.8)
Other opiate users 49 (3.7) 39 (4.2) 62 (6.4) 48 (4.3) 46 (4.9)
Valid number 1337 933 969 1122 934
Overall, drug users presenting for treatment were likely to use more than one drug (Table 6a). Trends in secondary
drug use show high levels of polydrug use among drug users attending treatment, although the proportion decreased
slightly from 76 per cent in 1996 to 70 per cent in 2000 (Table 6a). Opiates, benzodiazepines and cannabis were the
drugs most likely to be involved. In 1999 and 2000, there was a shift from opiates to benzodiazepines as the most
common secondary drug (Table 6a). There has been a small but steady increase in the use of cocaine as a secondary
drug from three per cent in 1996 to seven per cent in 2000 (Table 6a). Injecting cocaine as a secondary drug was
closely associated with injecting heroin as a main drug (not shown in table). 
Risk behaviour
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Table 6a   Reported second problem drug and second drug type for all cases attending treatment in the
Republic of Ireland and recorded in the National Drug Treatment Reporting System, 1996 to 2000
Secondary drug misuse 1996 1997 1998 1999 2000
Number (%)
No secondary drug 1112 (23.8) 1167 (24.2) 1787 (29.6) 1968 (30.5) 2068 (29.6)
Opiates 1027 (22.0) 1066 (22.1) 1071 (17.7) 990 (15.4) 893 (12.8)
Cannabis 776 (16.6) 648 (13.4) 930 (15.4) 986 (15.3) 1052 (15.0)
Benzodiazepines 755 (16.2) 951 (19.7) 1039 (17.2) 1094 (17.0) 1258 (18.0)
Ecstasy 380 (8.1) 340 (7.0) 373 (6.2) 437 (6.8) 566 (8.1)
Alcohol 247 (5.3) 173 (3.6) 219 (3.6) 225 (3.5) 368 (5.3)
Cocaine 121 (2.6) 196 (4.1) 292 (4.8) 442 (6.9) 502 (7.2)
Amphetamines 77 (1.7) 113 (2.3) 176 (2.9) 160 (2.5) 140 (2.0)
Volatile inhalants 11 (0.2) 12 (0.2) 6 (0.1) 16 (0.3) 21 (0.3)
Other substances 161 (3.4) 160 (3.3) 150 (2.5) 125 (1.9) 126 (1.8)
Valid number 4667 4826 6043 6443 6994
Among new cases, there were high levels of polydrug use (Table 6b). In these cases the pattern was somewhat
different with cannabis as the drug most likely to be involved (in 18 per cent of cases in 1999 and 2000), followed by
ecstasy and benzodiazepines (Table 6b).  Increasing alcohol use as a second drug was also reported (Table 6b). Among
new clients, there was a small increase in the use of cocaine as a secondary drug, from three per cent in 1996 to four
per cent in 2000.
Table 6b   Reported second problem drug and second drug type for new cases attending treatment in the
Republic of Ireland and recorded in the National Drug Treatment Reporting System, 1996 to 2000
Secondary drug misuse 1996 1997 1998 1999 2000
Number (%)
No secondary drug 515 (26.5) 445 (29.7) 521 (32.1) 670 (36.3) 583 (29.5)
Cannabis 392 (20.2) 262 (17.5) 330 (20.3) 330 (17.9) 361 (18.3)
Opiates 267 (13.7) 167 (11.1) 136 (8.4) 138 (7.5) 146 (7.4)
Benzodiazepines 220 (11.3) 196 (13.1) 142 (8.8) 159 (8.6) 147 (7.4)
Ecstasy 215 (11.1) 163 (10.9) 173 (10.7) 226 (12.2) 317 (16.0)
Alcohol 141 (7.3) 76 (5.1) 104 (6.4) 100 (5.4) 207 (10.5)
Cocaine 50 (2.6) 48 (3.2) 60 (3.7) 86 (4.7) 71 (3.6)
Amphetamines 58 (3.0) 72 (4.8) 100 (6.2) 98 (5.3) 83 (4.2)
Volatile inhalants 9 (0.5) 4 (0.3) 4 (0.3) 9 (0.5) 15 (0.8)
Other substances 80 (4.1) 68 (4.5) 52 (3.2) 30 (1.6) 48 (2.4)
Valid number 1945 1501 1622 1846 1978
The increasing prevalence of high-risk behaviours, such as injecting and sharing practices associated with opiate and,
more recently, cocaine use has very serious implications for the future health of the population of drug users involved
in these practices. This is particularly the case in relation to the transmission of infectious diseases such as HIV, hepatitis
B and hepatitis C.
Over the five-year period under review, half of all cases had started to use drugs before the age of 15 (Tables 7a and
7b) and half of all injecting drug users had injected before the age of 19 (Tables 7a and 7b). Injecting drug use was a
major problem, with an increasing number of cases having injected at some time in the past (2555 in 1996 increased
to 4484 in 2000) (Table 7a). 
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Table 7a   Risk behaviours for all cases treated for problem drug use in the Republic of Ireland and reported
to the National Drug Treatment Reporting System, 1996 to 2000
Injecting and sharing status 1996 1997 1998 1999 2000
Median age (range)* started drug use in years 15 (11-21) 15 (11-22) 15 (11-22) 15 (11-21) 15 (11-21)
Median age (range)* started injecting in years 18 (14-27) 19 (15-28) 19 (15-27) 19 (14-28) 19 (14-28)
Number injector status known 4683 4767 5694 6271 6829
Number (%) ever injected 2555 (54.6) 2979 (62.5) 3750 (65.9) 4323 (68.9) 4484 (65.7)
Of whom:†
‘ever shared’ 1533 (68.8) 1798 (71.1) 2207 (70.3) 2767 (75.5) 3000 (75.9)
‘currently injecting’ 1492 (61.0) 1694 (62.3) 1976 (58.4) 1860 (49.3) 1894 (47.8)
‘currently sharing’ 382 (30.8) 461 (34.1) 519 (32.7) 495 (30.5) 476 (28.8)
Table 7b   Risk behaviours for new cases treated for problem drug use in the Republic of Ireland an
reported to the National Drug Treatment Reporting System, 1996 to 2000
Injecting and sharing status 1996 1997 1998 1999 2000
Median age (range)* started drug use in years 15 (11-21) 15 (11-23) 15 (11-22) 15 (11-22) 15 (11-22)
Median age (range)* started injecting in years 19 (15-28) 19 (15-29) 19 (15-28) 19 (15-30) 19 (15-31)
Number injector status known 1960 1470 1545 1795 1933
Number (%) ever injected 631 (32.2) 545 (37.1) 573 (37.1) 790 (44.0) 624 (32.3)
Of whom:† 
‘ever shared 278 (50.5) 249 (55.6) 253 (54.6) 435 (65.7) 312 (61.1) 
‘currently injecting’ 416 (66.8) 367 (70.0) 352 (66.3) 364 (56.8) 325 (60.5) 
‘currently sharing’ 117 (32.1) 114 (36.7) 93 (32.2) 110 (32.2) 79 (27.4)
* Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest because not all declared
injectors were asked the subsequent injecting questions. 
Levels of risk behaviours were not as high among those attending treatment for the first time (Table 7b). In 2000 just one-
third (624/1933) had ever injected. This indicates that treatment services have the opportunity to prevent two-thirds of
those seeking treatment from moving to injecting, rather than smoking or snorting, heroin or cocaine respectively. 
National trends
* Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
† From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest as not all known injectors
had completed the subsequent injecting questions. 
Figure 1 presents the incidence and prevalence of treated drug misuse in the Republic of Ireland. As the majority of
people treated for problem drug use were in the 15 to 39 year age group, the rates for the Republic of Ireland were
calculated based on this age group of the population. Between 1997 and 2000, the incidence of treated drug misuse
increased gradually, from 10.3 to 12.4 per 10,000 of the 15 to 39 year population, but never returned to the high
incidence rate of 13.9 in 1996. Over the same time period, the prevalence of treated drug misuse increased from 33.0
to 44.3, indicating that a large proportion of drug users who were previously treated for drug misuse require continued
care and place a heavy burden on treatment services. 
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Figure 1   Incidence and prevalence of treated drug misuse among persons aged between 15 and 39 years in
the Republic of Ireland per 10,000 population, 1996 to 2000 (Central Statistics Office 2002) 
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